Zivo Bioscience, Inc.
ZIVO· OTC
Filed Mar 31, 2014 · 10-K · 90 days after period end · 0001078782-14-000496
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $4.05K |
| Net Income | $261.21K | — | -$1.41M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 31, 2014 · 90 d after period end